John M. Sprague - Feb 20, 2022 Form 4/A - Amendment Insider Report for T2 Biosystems, Inc. (TTOO)

Signature
/s/ Michael Gibbs, Attorney-in-fact
Stock symbol
TTOO
Transactions as of
Feb 20, 2022
Transactions value $
-$1,759
Form type
4/A - Amendment
Date filed
3/29/2022, 04:17 PM
Date Of Original Report
Feb 23, 2022
Next filing
Mar 29, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TTOO Common Stock Options Exercise +10K +22.02% 55.4K Feb 21, 2022 Direct F1, F2
transaction TTOO Common Stock Tax liability -$1.76K -3.78K -6.81% $0.47 51.6K Feb 21, 2022 Direct F3, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TTOO Restricted Stock Units Award $0 +600K $0.00 600K Feb 20, 2022 Common Stock 600K Direct F1, F5
transaction TTOO Restricted Stock Units Options Exercise $0 -10K -100% $0.00* 0 Feb 21, 2022 Common Stock 10K Direct F1, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
F2 Includes 3,968 shares acquired under the Issuer's employee stock purchase plan ("ESPP") on May 15, 2021 and 5,961 shares acquired under the ESPP on November 15, 2021.
F3 3,775 shares of common stock were automatically withheld at vesting to cover required tax withholding.
F4 The Form 4, as originally filed, incorrectly reported the amount of beneficially owned securities as 138,775.
F5 On February 20, 2022 the reporting person was granted 600,000 RSU's that vest in three equal installments commencing on February 20, 2023.
F6 On February 21, 2019 the reporting person was granted 30,000 RSU's that vest in three equal annual installments beginning on February 21, 2020.